ADCs |
Antibody-Drug Conjugates |
ADT |
Androgen Deprivation Therapy |
Ala |
Alanine |
BBB |
Blood–Bain–Barrier |
Cit |
Citrulline |
DAR |
Drug-Antibody Ratio |
DDI |
Drug-Drug Interactions |
DIO |
Diet-Induced Obese |
DOTA |
1,4,7,10-Tetraazacyclododeane |
DPP4 |
Dipeptidyl Peptidase 4 |
DTNP |
5,5′-Disulfanediylbis(2-nitrobenzoic acid) or Ellman’s reagent |
GHIH |
Growth Hormone-Inhibiting Hormone |
GIP |
Gastric Inhibitory Polypeptide |
GLP-1 |
Glucagon-Like Peptide 1 |
GLP-2 |
Glucagon-Like Peptide 2 |
gGlu |
gamma glutamic acid |
GnRH |
Gonadotropin-Releasing Hormone |
LHRH |
Luteinizing Hormone-Releasing Hormone |
LRP1 |
Low-Density Lipoprotein Receptor-Related Protein 1 |
NSCLC |
Non-Small Cell Lung Cancer |
PABC |
p-Aminobenzyl Carbamate |
PRRT |
Peptide Receptor Radionuclide Therapy |
PSMA |
Prostate Specific Membrane Antigen |
PTH |
Parathyroid Hormone |
SERCA |
the Sarco/Endoplasmic Reticulum Calcium ATPase |
SSTR |
Somatostatin Receptor |